Hamamelitannin

Hamamelitannin at a Glance

Hamamelitannin — 2’,5-di-O-galloyl-D-hamamelose — is the characteristic hydrolysable tannin of witch hazel bark, and the molecule most often credited with the herb’s pharmacology. Structurally it is a small gallotannin: two gallic acid units esterified not to glucose but to hamamelose, a branched-chain sugar named after the plant. At roughly 484 Da it is at the small end of the hydrolysable-tannin class — a fraction of the size of its glucose-cored relative pentagalloylglucose — and it makes up 1–7% of dried bark ^{7,12Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 12Vennat B et al. · 1988Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts — phytochemical analysisView study →}.

Its research profile has three genuinely interesting parts: a strong radical-scavenging and cytoprotective action in skin cells ^{9,10Reference 9Masaki H et al. · 1995In vitroProtective activity of hamamelitannin on cell damage induced by superoxide anion radicals in murine dermal fibroblasts — in vitroView study →Reference 10Masaki H et al. · 1995In vitroProtective activity of hamamelitannin on cell damage of murine skin fibroblasts induced by UVB irradiation — in vitroView study →}, potent 5-lipoxygenase inhibition ^{11Reference 11Hartisch C et al. · 1997In vitroDual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipoxygenase and lyso-PAF: acetyl-CoA acetyltransferase — in vitroView study →}, and — the most distinctive of the three — a non-peptide quorum-sensing inhibitor activity that makes Staphylococcus aureus biofilms more susceptible to antibiotics without killing the bacteria ^{1,2Reference 1Kiran MD et al. · 2008In vitroDiscovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening — in vitro/animal modelView study →Reference 2Brackman G et al. · 2016In vitroThe quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release — in vitro/animal modelView study →}.

Two caveats do most of the work here, and both are load-bearing. First, the product problem: the witch hazel almost everyone buys is a steam distillate that contains essentially no tannin, so it contains essentially no hamamelitannin. Second, the isolate problem: at least one careful study of witch hazel bark found the extract’s anti-inflammatory and antibacterial activity tracked the condensed tannins, with purified hamamelitannin inactive ^{7Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →} — so the molecule should not be treated as a stand-in for the herb.

The Product Problem: Witch Hazel Water Has Almost None Of It

This belongs at the top because it reframes everything below it.

The witch hazel on pharmacy shelves is, overwhelmingly, Hamamelis Water — the steam distillate of the USP monograph, made by macerating recently cut dormant twigs in water and distilling, then adding alcohol to a final 14–15% ethanol as a preservative ^{27Reference 27United States PharmacopeiaReviewWitch Hazel (Hamamelis Water) — official monographView study →}. Steam distillation carries over volatiles, not tannins. Hamamelitannin is a polar, non-volatile, thermally labile polyphenol; it does not distil. Reviews and primary chemical work on the herb state it plainly: tannins are almost entirely absent from distillates prepared from the same plant material ^{7,15Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 15Wójciak M et al. · 2025ReviewHamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — reviewView study →}.

The consequences are not cosmetic:

• The astringency people buy witch hazel for is a tannin effect, and the distillate is not a tannin preparation. Whatever the retail product does, it is not doing it by protein precipitation.
• The human trial record is mostly about the distillate, not this molecule. The controlled dermatology studies — UV-erythema models and the atopic-eczema comparison against hydrocortisone — tested standardised Hamamelis distillate ^{15,29Reference 15Wójciak M et al. · 2025ReviewHamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — reviewView study →Reference 29Korting HC et al. · 1995RCTComparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema — double-blind randomised controlled trialView study →}. None of them is evidence about hamamelitannin.
• The preclinical record is mostly about the bark, where hamamelitannin actually lives ^{7,14,23Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 14Skowrońska W et al. · 2025In vitroChemical composition, skin microbiota metabolism, antimicrobial potential and anti-inflammatory properties of witch hazel bark (Hamamelis virginiana L.) — in vitro/ex vivoView study →Reference 23Touriño S et al. · 2008In vitroHighly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells — in vitroView study →}.

So the two literatures barely touch. The molecule with the pharmacology is concentrated in a preparation (bark decoction or hydroalcoholic bark extract) that few people use, and the preparation most people use is largely stripped of it. Any claim that runs “witch hazel does X because hamamelitannin does X” has to specify which preparation, or it is wrong by default.

The alcohol matters too: at 14–15% ethanol, commercial witch hazel water is itself mildly drying and antiseptic, which plausibly accounts for part of what users experience and is often mistaken for a tannin effect.

The Hamamelose Core

Hamamelitannin is a gallotannin with an unusual scaffold, and that scaffold is why it is a named molecule rather than an anonymous member of the tannin pool.

The sugar is branched. Hamamelose is 2-C-(hydroxymethyl)-D-ribose — a branched-chain sugar carrying an extra hydroxymethyl arm at C-2 ^{13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →}. Nearly every other hydrolysable tannin in common plants is built on ordinary D-glucose. Hamamelitannin carries two galloyl esters (at the 2’ and 5 positions) on that branched core, giving C₂₀H₂₀O₁₄, MW ≈ 484.

Compared with pentagalloylglucose. The contrast with pentagalloylglucose (PGG, MW ≈ 940, five galloyls on glucose) is instructive and has a measured pharmacological consequence. PGG’s dense galloyl surface makes it a promiscuous protein binder — powerful, but indiscriminate. Hamamelitannin, with two galloyls on a different sugar, binds proteins less aggressively, and in the one head-to-head study of the two against colon-cancer cells that difference showed up as selectivity: at concentrations that halved HT29 tumour-cell growth, hamamelitannin left normal NCM460 colonocytes unharmed, while PGG inhibited both ^{4Reference 4Sánchez-Tena S et al. · 2012In vitroHamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells — in vitroView study →}. Fewer galloyls is not simply “weaker” — here it reads as a cleaner window.

Where astringency actually comes from. Because it is small and only doubly galloylated, hamamelitannin is a weaker protein-precipitant than the bark’s other major tannin fraction — the polymeric proanthocyanidins (degree of polymerisation ~11–29, heavily galloylated) that make up the condensed-tannin half of the bark ^{7,23Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 23Touriño S et al. · 2008In vitroHighly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells — in vitroView study →}. Hamamelitannin contributes to astringency; the polymers carry most of it. This is worth saying because the herbal literature routinely credits hamamelitannin with the whole astringent action.

A family, not a single compound. Hamamelis bark and leaf contain a set of related galloylhamameloses beyond hamamelitannin itself ^{28Reference 28Haberland C · 1994Novel galloylhamameloses from Hamamelis virginiana — phytochemical analysisView study →}, and modern LC-MS profiling of the leaf annotates 18 distinct gallotannins with hamamelitannin as one reference standard among them ^{26Reference 26Burico M et al. · 2022Metabolomic fingerprint of Hamamelis virginiana L. gallotannins by suspect screening analysis with UHPLC-qToF and their semiquantitative evaluation — phytochemical analysisView study →}. Analytical work that reports “hamamelitannin content” is usually resolving one peak out of that family.

Quorum Sensing: An Anti-Virulence Lead

The most consequential thing hamamelitannin does has nothing to do with astringency, antioxidants or skin.

Discovery. In 2008 a structure-based virtual screen looked for small molecules that mimic RNAIII-inhibiting peptide (RIP), a peptide known to block staphylococcal quorum sensing. The screen returned hamamelitannin. It behaves as RIP does: it inhibits the quorum-sensing regulator RNAIII and it has no effect on staphylococcal growth in vitro — it disarms the organism rather than killing it. In a rat graft model it prevented device-associated infection, including by MRSA and S. epidermidis ^{1Reference 1Kiran MD et al. · 2008In vitroDiscovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening — in vitro/animal modelView study →}.

Mechanism. Follow-up work localised the effect to the TraP receptor and showed what downstream changes make biofilms vulnerable: hamamelitannin alters cell-wall (peptidoglycan) synthesis and extracellular DNA release, and through that it increases the susceptibility of S. aureus biofilms to several different classes of antibiotic — demonstrated in vitro, in Caenorhabditis elegans, and in a mouse mammary-gland infection model ^{2Reference 2Brackman G et al. · 2016In vitroThe quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release — in vitro/animal modelView study →}. Independent work found hamamelitannin at sub-inhibitory concentrations reduced bacterial metabolic activity without inhibiting growth, and inhibited biofilms of all tested bacteria in vivo in a catheter-related-infection model, where it was the most effective of the three agents compared ^{17,18Reference 17Cobrado L et al. · 2013AnimalIn vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections — animal modelView study →Reference 18Cobrado L et al. · 2012In vitroCerium, chitosan and hamamelitannin as novel biofilm inhibitors? — in vitroView study →}.

What is hamamelitannin and what is not. This distinction matters and is often blurred:

Finding	Compound actually tested
RIP-mimetic discovery; RNAIII inhibition; rat graft model 1Reference 1Kiran MD et al. · 2008In vitroDiscovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening — in vitro/animal modelView study →	hamamelitannin itself
TraP receptor; peptidoglycan/eDNA mechanism; C. elegans + mouse mastitis 2Reference 2Brackman G et al. · 2016In vitroThe quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release — in vitro/animal modelView study →	hamamelitannin itself
In-vivo catheter biofilm inhibition 17,18Reference 17Cobrado L et al. · 2013AnimalIn vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections — animal modelView study →Reference 18Cobrado L et al. · 2012In vitroCerium, chitosan and hamamelitannin as novel biofilm inhibitors? — in vitroView study →	hamamelitannin itself
Cyclodextrin-complexed wound dressings 19Reference 19Brackman G et al. · 2016In vitroDressings loaded with cyclodextrin-hamamelitannin complexes increase Staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communities — in vitroView study →	hamamelitannin, formulated
58-compound analogue series; the potent antibiotic potentiator 3Reference 3Vermote A et al. · 2016In vitroHamamelitannin analogues that modulate quorum sensing as potentiators of antibiotics against Staphylococcus aureus — in vitro/animal modelView study →	synthetic analogues, not the natural product

The 2016 medicinal-chemistry programme built 58 hamamelitannin analogues and identified one that raises S. aureus susceptibility to antibiotics in vitro, in C. elegans and in a mouse mammary-gland infection model without cytotoxicity ^{3Reference 3Vermote A et al. · 2016In vitroHamamelitannin analogues that modulate quorum sensing as potentiators of antibiotics against Staphylococcus aureus — in vitro/animal modelView study →}. That is a genuinely promising anti-virulence lead — but it is a designed molecule, and its potency should not be back-attributed to the natural product, still less to witch hazel.

The honest ceiling. This is systemic/device pharmacology in animals. Nobody has shown that a topical witch hazel preparation delivers enough hamamelitannin to disarm a staphylococcal biofilm on human skin, and the one witch hazel bark study that looked specifically found the extract had no antibacterial or antibiofilm activity in its acne model ^{7Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →}.

What It's Used For

Hamamelitannin is unusually well studied for a single plant tannin, but the evidence is entirely preclinical, and the two threads — skin-directed antioxidant/anti-inflammatory work and antimicrobial anti-virulence work — sit in different literatures.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. There are no human trials of this molecule, so every score is capped by design and reflects preclinical isolate evidence only.

01Anti-Virulence & AntibiofilmPromising48%Defined receptor (TraP/RNAIII), non-bactericidal, multiple in-vivo animal models, analogue programme ^{1,2,3,17,18,19Reference 1Kiran MD et al. · 2008In vitroDiscovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening — in vitro/animal modelView study →Reference 2Brackman G et al. · 2016In vitroThe quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release — in vitro/animal modelView study →Reference 3Vermote A et al. · 2016In vitroHamamelitannin analogues that modulate quorum sensing as potentiators of antibiotics against Staphylococcus aureus — in vitro/animal modelView study →Reference 17Cobrado L et al. · 2013AnimalIn vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections — animal modelView study →Reference 18Cobrado L et al. · 2012In vitroCerium, chitosan and hamamelitannin as novel biofilm inhibitors? — in vitroView study →Reference 19Brackman G et al. · 2016In vitroDressings loaded with cyclodextrin-hamamelitannin complexes increase Staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communities — in vitroView study →}

02Antioxidant & PhotoprotectionShaky42%Fibroblast superoxide/UVB protection with quantified IC50s; SOD/CAT/GPx induction; galloylated-fraction work ^{9,10,8,23Reference 9Masaki H et al. · 1995In vitroProtective activity of hamamelitannin on cell damage induced by superoxide anion radicals in murine dermal fibroblasts — in vitroView study →Reference 10Masaki H et al. · 1995In vitroProtective activity of hamamelitannin on cell damage of murine skin fibroblasts induced by UVB irradiation — in vitroView study →Reference 8Janarthanam VA et al. · 2025In vitroIn vitro and in silico evaluation of the antioxidant and anticancer potential of hamamelitannin from Hamamelis virginiana — in vitro/in silicoView study →Reference 23Touriño S et al. · 2008In vitroHighly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells — in vitroView study →}

03Anti-Inflammatory (Skin)Shaky34%5-LOX IC50 1.0–18.7 µM; keratinocyte IL-4-pathway effects — but contested by a same-group negative result ^{11,6,7,14Reference 11Hartisch C et al. · 1997In vitroDual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipoxygenase and lyso-PAF: acetyl-CoA acetyltransferase — in vitroView study →Reference 6Piazza S et al. · 2022In vitroUnveiling the ability of witch hazel (Hamamelis virginiana L.) bark extract to impair keratinocyte inflammatory cascade typical of atopic eczema — in vitroView study →Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 14Skowrońska W et al. · 2025In vitroChemical composition, skin microbiota metabolism, antimicrobial potential and anti-inflammatory properties of witch hazel bark (Hamamelis virginiana L.) — in vitro/ex vivoView study →}

04Cytoprotection Against TNFShaky30%Complete protection against TNF-induced endothelial death >10 µM; adhesion molecules unaffected ^{5Reference 5Habtemariam S · 2002In vitroHamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro — in vitroView study →}

05Anticancer (In Vitro)Shaky28%Selective HT29 cytotoxicity sparing normal colonocytes; HepG2 apoptosis + docking ^{4,8,22Reference 4Sánchez-Tena S et al. · 2012In vitroHamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells — in vitroView study →Reference 8Janarthanam VA et al. · 2025In vitroIn vitro and in silico evaluation of the antioxidant and anticancer potential of hamamelitannin from Hamamelis virginiana — in vitro/in silicoView study →Reference 22Rippin et al. · 2023ReviewGinnalin A and hamamelitannin: the unique gallotannins with promising anti-carcinogenic potential — reviewView study →}

06Neuro- & Hepatoprotection (Zebrafish)Shaky20%Two zebrafish-larva oxidative-stress models from one group ^{21,20Reference 21Janarthanam VA et al. · 2025AnimalEvaluating the antioxidant-mediated neuroprotection of hamamelitannin against H2O2-induced oxidative damage — animal modelView study →Reference 20Janarthanam VA et al. · 2026AnimalHamamelitannin from Hamamelis virginiana attenuates ethanol-induced oxidative and inflammatory responses in Danio rerio larvae — animal modelView study →}

Mechanisms

The pattern is a molecule with two unrelated strengths: a redox/enzyme arm shared with the gallotannin class, and a receptor-specific anti-virulence arm that is genuinely its own. The quorum-sensing activity is the only one that would be hard to substitute with another polyphenol.

Pharmacokinetics

There are no pharmacokinetic data for hamamelitannin — none. No human or animal absorption, distribution or excretion study exists; the compound has never been dosed for a PK endpoint. What can be said rests on chemistry and on class behaviour, and should be read as inference:

• Size cuts both ways. At ~484 Da hamamelitannin is small for a hydrolysable tannin (roughly half of PGG), but it carries eight phenolic hydroxyls on a polar sugar — a profile that predicts poor passive absorption across the gut wall and across intact skin.
• It is an ester, so it hydrolyses. Gastric acid, intestinal esterases and gut microbiota would be expected to cleave the galloyl esters to gallic acid and free hamamelose. Note that hamamelitannin is a gallotannin, not an ellagitannin: the gallic-acid → pyrogallol / 4-O-methylgallic-acid route is the expected fate, not the ellagitannin → ellagic acid → urolithin pathway that dominates the pomegranate literature.
• One measured metabolic observation exists, and it is topical. When witch hazel bark extract was incubated with skin microbiota, the principal metabolite generated was ellagic acid, which itself stimulated inflammatory-mediator release from fibroblasts ^{14Reference 14Skowrońska W et al. · 2025In vitroChemical composition, skin microbiota metabolism, antimicrobial potential and anti-inflammatory properties of witch hazel bark (Hamamelis virginiana L.) — in vitro/ex vivoView study →}. That is an extract-level result (the bark contains ellagitannins as well as hamamelitannin), but it is the only biotransformation data the herb has, and it points at a metabolite that may work against the parent’s anti-inflammatory effect.

The practical consequence. The in-vitro concentrations in this literature — 10–200 µM — are reachable in two compartments and essentially nowhere else: on the skin surface under a topical bark extract, and in the gut lumen after swallowing a tannin-rich preparation. That is exactly where the strongest results sit (fibroblast/keratinocyte protection, selective HT29 colonocyte cytotoxicity, surface biofilms). Plasma concentrations after any realistic exposure are unknown and almost certainly far lower, so any systemic reading of this data is unsupported.

Clinical Trials

There are no clinical trials of isolated hamamelitannin. The human trials associated with witch hazel — UV-erythema models, the atopic-eczema comparison against hydrocortisone, antiseptic formulations — all tested Hamamelis distillate, the preparation that contains essentially none of this molecule ^{15,29Reference 15Wójciak M et al. · 2025ReviewHamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — reviewView study →Reference 29Korting HC et al. · 1995RCTComparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema — double-blind randomised controlled trialView study →}. That is not a small caveat; it means the herb’s human evidence base and this molecule’s evidence base do not overlap at all.

Last checked: August 2026.

Isolate vs. Plant Studies

Hamamelitannin is one of the better cases of a plant tannin studied as a pure compound: the quorum-sensing work ^{1,2,3Reference 1Kiran MD et al. · 2008In vitroDiscovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening — in vitro/animal modelView study →Reference 2Brackman G et al. · 2016In vitroThe quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release — in vitro/animal modelView study →Reference 3Vermote A et al. · 2016In vitroHamamelitannin analogues that modulate quorum sensing as potentiators of antibiotics against Staphylococcus aureus — in vitro/animal modelView study →}, the fibroblast photoprotection ^{9,10Reference 9Masaki H et al. · 1995In vitroProtective activity of hamamelitannin on cell damage induced by superoxide anion radicals in murine dermal fibroblasts — in vitroView study →Reference 10Masaki H et al. · 1995In vitroProtective activity of hamamelitannin on cell damage of murine skin fibroblasts induced by UVB irradiation — in vitroView study →}, the 5-LOX inhibition ^{11Reference 11Hartisch C et al. · 1997In vitroDual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipoxygenase and lyso-PAF: acetyl-CoA acetyltransferase — in vitroView study →}, the TNF-cytoprotection ^{5Reference 5Habtemariam S · 2002In vitroHamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro — in vitroView study →} and the HT29 selectivity ^{4Reference 4Sánchez-Tena S et al. · 2012In vitroHamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells — in vitroView study →} all use the isolated molecule. On the usual axis, that is a strength — the activity is attributable to this structure.

The transfer problem here is not “isolate vs extract” in the usual direction. It runs three ways:

1. Isolate → herb fails at the preparation step. The molecule is in the bark; the commercial product is the distillate. There is no route from a hamamelitannin result to a claim about witch hazel water ^{7,15Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 15Wójciak M et al. · 2025ReviewHamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — reviewView study →}.
2. Isolate → herb is directly contradicted in one model. In the C. acnes keratinocyte study, the bark extract was anti-inflammatory but purified hamamelitannin was inactive, and the authors attributed the effect to the proanthocyanidins ^{7Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →}. A 2025 study reached the opposite conclusion, ranking hamamelitannin among the most active anti-inflammatory components ^{14Reference 14Skowrońska W et al. · 2025In vitroChemical composition, skin microbiota metabolism, antimicrobial potential and anti-inflammatory properties of witch hazel bark (Hamamelis virginiana L.) — in vitro/ex vivoView study →}. Both are in vitro; the disagreement is unresolved and should be reported as such.
3. Herb → isolate over-credits the molecule. Witch hazel bark is 8–12% total tannin, of which hamamelitannin is 1–7% of dry weight and the polymeric proanthocyanidins (isolated at ~5% yield) are the other major fraction ^{7,23Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 23Touriño S et al. · 2008In vitroHighly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells — in vitroView study →}. The astringency, and a good share of the antioxidant capacity, belong to that polymeric pool. The same pattern shows up in the herb’s antiviral work: when bark-extract fractions were tested against influenza A virus and human papillomavirus, the activity tracked the high-molecular-weight condensed tannins, not the gallotannins ^{24Reference 24Theisen LL et al. · 2014In vitroTannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus — in vitroView study →}. Crediting hamamelitannin with witch hazel’s whole pharmacology is a habit of the secondary literature, not a finding.

The honest summary: strong, specific, isolate-level mechanism — especially the anti-virulence work — with no human data and a broken chain to the products people actually buy.

Its Role in Plants

Hamamelitannin is a defensive tannin and, unusually, a marker of a distinctive sugar metabolism.

Hydrolysable tannins deter herbivores and pathogens by precipitating dietary and salivary proteins and by binding microbial enzymes; in Hamamelis the tannin pool is concentrated in the bark, the tissue most exposed to browsing and infection, and drops sharply through leaf to stem ^{12Reference 12Vennat B et al. · 1988Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts — phytochemical analysisView study →}. The quorum-sensing inhibition described above is a plausible extension of that defensive role — a plant compound that disrupts bacterial coordination without imposing the selection pressure that a bactericide would.

Biosynthetically it is built from two familiar halves. Gallic acid comes from the shikimate pathway, as in every gallotannin. The other half is the oddity: hamamelose, a branched-chain sugar (2-C-hydroxymethyl-D-ribose) formed by a rearrangement in the carbohydrate pathway rather than by ordinary hexose metabolism ^{13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →}. Galloylation of hamamelose produces hamamelitannin along with a set of related galloylhamameloses ^{28Reference 28Haberland C · 1994Novel galloylhamameloses from Hamamelis virginiana — phytochemical analysisView study →}. Tannin composition is also sensitive to processing: thermal treatment breaks larger gallotannins down into simpler ones and shifts the antioxidant profile ^{25Reference 25González MJ et al. · 2010In vitroImpact of thermal processing on the activity of gallotannins and condensed tannins from Hamamelis virginiana used as functional ingredients in seafood — in vitroView study →}.

Prevalence in Nature

Hamamelitannin is not the ubiquitous polyphenol that gallic acid or catechin is — it is essentially a Hamamelis compound with a small number of documented relatives elsewhere.

Witch hazel is the anchor. In Hamamelis virginiana the distribution across tissues is steep: one quantitative study found the bark extract 31× richer in hamamelitannin than the leaf extract and 87× richer than the stem ^{12Reference 12Vennat B et al. · 1988Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts — phytochemical analysisView study →}. The EMA/HMPC monograph assessment puts bark tannin content at 8–12% (leaf 3–10%) with hamamelitannin at 1–7% of the bark — the herb’s characteristic constituent ^{7Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →}. In a glycolic bark extract the measured figure was 0.29% w/w hamamelitannin against 0.30% w/w condensed tannins, which shows how much extraction solvent and method move the number ^{7Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →}.

Beyond Hamamelis. Galloylhamameloses have been isolated from the bark of several Fagaceae — Castanea crenata, Castanopsis cuspidata and Castanea sativa (sweet chestnut) — and hamamelitannin for commercial and research use is isolated from witch hazel or sweet chestnut ^{13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →}. Two clarifications that the popular literature gets wrong:

• Hamamelose itself is not unique to Hamamelis. It was named for the plant it was first found in, but the branched sugar has since been detected across a wide range of vascular plants. What is characteristic of Hamamelis is the galloylated ester, not the sugar.
• PubMed attribution is clean but narrow. A search for hamamelitannin AND "Hamamelis virginiana" returns 21 records, and the compound is documented in H. virginiana specifically. Searching hamamelitannin against H. japonica or H. mollis returns zero records — there is no published work assigning this molecule to the Asian witch hazels, so results from them should not be merged in.

Major Natural Sources

Source	Plant part	Reported hamamelitannin level
Witch hazel (Hamamelis virginiana)	bark	1–7% dry wt 7Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →; 31× the leaf, 87× the stem 12Reference 12Vennat B et al. · 1988Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts — phytochemical analysisView study →
Witch hazel (Hamamelis virginiana)	leaf	present; a fraction of bark levels 12,26Reference 12Vennat B et al. · 1988Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts — phytochemical analysisView study →Reference 26Burico M et al. · 2022Metabolomic fingerprint of Hamamelis virginiana L. gallotannins by suspect screening analysis with UHPLC-qToF and their semiquantitative evaluation — phytochemical analysisView study →
Witch hazel (Hamamelis virginiana)	stem	present; lowest of the three 12Reference 12Vennat B et al. · 1988Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts — phytochemical analysisView study →
Witch hazel — steam distillate (“witch hazel water”)	—	essentially absent 7,15Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 15Wójciak M et al. · 2025ReviewHamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — reviewView study →
Sweet chestnut (Castanea sativa)	bark	present; a commercial isolation source 13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →
Japanese chestnut (Castanea crenata), Castanopsis cuspidata	bark	galloylhamameloses reported 13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →

Discovery & Synthesis

Hamamelitannin belongs to the classical era of tannin chemistry. It has long been recognised as the characteristic tannin of Hamamelis bark — the name of the compound, of the sugar (hamamelose) and of the plant all share a root — and its structure was settled by Mayer and colleagues in 1965 ^{13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →}. Quantitative separation of hamamelitannin from the bark’s proanthocyanidins came later, with the 1988 HPLC work that established the bark/leaf/stem gradient ^{12Reference 12Vennat B et al. · 1988Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts — phytochemical analysisView study →}, and a family of additional galloylhamameloses was described in 1994 ^{28Reference 28Haberland C · 1994Novel galloylhamameloses from Hamamelis virginiana — phytochemical analysisView study →}.

Total synthesis has been essentially a one-off. A single total synthesis was published in 1969, obtaining the target di-O-acyl glycoside in only 22% yield by conventional acylation — an overall yield in the low teens across the sequence — and no improved route has displaced it ^{13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →}. Modern interest has shifted to enzymatic acylation of D-hamamelose as a cleaner, regioselective way to make hamamelitannin and its analogues ^{13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →}, which is also how the medicinal-chemistry programme built its 58-member analogue library for the anti-virulence work ^{3Reference 3Vermote A et al. · 2016In vitroHamamelitannin analogues that modulate quorum sensing as potentiators of antibiotics against Staphylococcus aureus — in vitro/animal modelView study →}.

Supply today is by extraction from plant material — witch hazel bark, or sweet chestnut — rather than synthesis ^{13Reference 13Mastihubová M · 2023ReviewFrom hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — reviewView study →}. Research-grade hamamelitannin is a reference standard rather than a bulk commodity, and there is no standardised hamamelitannin-content consumer product.

Patents: not yet researched.

Toxicity & Safety

Hamamelitannin carries a low toxicity flag. It is a constituent of a herb with a long pharmacopoeial history of topical use, no reported organ toxicity, and no adverse-event signal of its own. Its cautions are those of the hydrolysable-tannin class, plus two specific in-vitro flags worth stating honestly.

The tannin-class cautions. Like other hydrolysable tannins it binds proteins and would be expected to reduce non-heme iron absorption and to cause astringency or gastric irritation if a concentrated bark preparation were swallowed. Oral use of tannin-rich witch hazel bark is uncommon and not well characterised.

The concentration-dependent flip. Highly galloylated witch hazel bark tannin fractions are potent antioxidants at low concentrations but become mildly pro-oxidant and cytotoxic to skin cells at higher ones ^{23Reference 23Touriño S et al. · 2008In vitroHighly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells — in vitroView study →} — the standard polyphenol hormesis pattern, and a reason not to assume “more tannin is better” in a topical.

The genotoxicity signal. In metabolically competent human hepatoma (Hep G2) cells, hamamelitannin produced a two-fold increase in DNA migration in the comet assay at up to 166 µg/mL — a mild, dose-independent genotoxic signal shared with the high-molecular-weight proanthocyanidin fraction, while catechin and the low-MW fraction were near-inert ^{16Reference 16Dauer A et al. · 2003In vitroGenotoxic and antigenotoxic effects of catechin and tannins from the bark of Hamamelis virginiana L. in metabolically competent, human hepatoma cells (Hep G2) using single cell gel electrophoresis — in vitroView study →}. The same study found hamamelitannin antigenotoxic against benzo(a)pyrene-induced damage, by scavenging the ultimate mutagen rather than by altering CYP or repair ^{16Reference 16Dauer A et al. · 2003In vitroGenotoxic and antigenotoxic effects of catechin and tannins from the bark of Hamamelis virginiana L. in metabolically competent, human hepatoma cells (Hep G2) using single cell gel electrophoresis — in vitroView study →}. It is a mixed in-vitro result in a liver cell line at concentrations no topical exposure approaches — worth recording, not worth alarm.

Safety at a Glance

✅ Low / no toxicity

• No toxicity signal in use. Hamamelitannin occurs in a herb accepted by European regulators for traditional topical use, with no reported organ toxicity and no adverse-event reports for the molecule itself ^{15Reference 15Wójciak M et al. · 2025ReviewHamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — reviewView study →}.
• Not the compound in your bottle. The steam-distilled witch hazel water of commerce contains essentially no tannin — a safety point as much as an efficacy one, since the retail product’s drying/antiseptic character comes largely from its 14–15% alcohol ^{7,15,27Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 15Wójciak M et al. · 2025ReviewHamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — reviewView study →Reference 27United States PharmacopeiaReviewWitch Hazel (Hamamelis Water) — official monographView study →}.
• Tannin-class effects on iron and the gut. Concentrated tannin-rich bark preparations bind dietary protein and non-heme iron and can irritate the stomach; separate them from iron-rich meals, and treat oral bark use as uncharacterised.
• Antioxidant at low concentration, pro-oxidant at high. Galloylated witch hazel tannin fractions turn mildly cytotoxic to skin cells above the effective antioxidant range ^{23Reference 23Touriño S et al. · 2008In vitroHighly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells — in vitroView study →}.
• A mild in-vitro genotoxicity flag. Two-fold comet-assay DNA migration in Hep G2 cells at up to 166 µg/mL, dose-independent, alongside a protective effect against benzo(a)pyrene ^{16Reference 16Dauer A et al. · 2003In vitroGenotoxic and antigenotoxic effects of catechin and tannins from the bark of Hamamelis virginiana L. in metabolically competent, human hepatoma cells (Hep G2) using single cell gel electrophoresis — in vitroView study →}. In vitro, one cell line, at concentrations topical use does not reach.
• No human, pharmacokinetic or interaction data exist. Nothing has been measured in people; the safety framing above is inference from tannin-class behaviour and the parent herb, not measurement. Absence of reports is not evidence of safety.

Pregnancy and lactation are decided per-herb and per-product, not on a molecule page; no reproductive-toxicity dataset exists for isolated hamamelitannin, and no verdict is issued here.

Dosage

There is no established human dose for hamamelitannin, and no product is standardised to it. Every number in the literature is a research figure:

None of these converts to a human dose. Two practical points instead:

• If you want the molecule, you want the bark — a bark decoction, or an aqueous/hydroalcoholic bark extract — not the distilled witch hazel water, which contains essentially none of it ^{7,15Reference 7Piazza S et al. · 2022In vitroAnti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitroView study →Reference 15Wójciak M et al. · 2025ReviewHamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — reviewView study →}.
• Topical and luminal exposure are the only plausible routes to the concentrations used in this research; nothing supports a systemic dose.

These are concentrations studied in research and are not a personal recommendation.

References

1. Kiran MD, Adikesavan NV, Cirioni O, et al. (2008). Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening — in vitro/animal model. Mol Pharmacol. https://pubmed.ncbi.nlm.nih.gov/18314496/
2. Brackman G, Breyne K, De Rycke R, et al. (2016). The quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release — in vitro/animal model. Sci Rep. https://pubmed.ncbi.nlm.nih.gov/26828772/
3. Vermote A, Brackman G, Risseeuw MDP, et al. (2016). Hamamelitannin analogues that modulate quorum sensing as potentiators of antibiotics against Staphylococcus aureus — in vitro/animal model. Angew Chem Int Ed Engl. https://pubmed.ncbi.nlm.nih.gov/27095479/
4. Sánchez-Tena S, Fernández-Cachón ML, Carreras A, et al. (2012). Hamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells — in vitro. J Nat Prod. https://pubmed.ncbi.nlm.nih.gov/22216935/
5. Habtemariam S. (2002). Hamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro — in vitro. Toxicon. https://pubmed.ncbi.nlm.nih.gov/11602283/
6. Piazza S, Martinelli G, Magnavacca A, et al. (2022). Unveiling the ability of witch hazel (Hamamelis virginiana L.) bark extract to impair keratinocyte inflammatory cascade typical of atopic eczema — in vitro. Int J Mol Sci. https://pubmed.ncbi.nlm.nih.gov/36012541/
7. Piazza S, Martinelli G, Vrhovsek U, et al. (2022). Anti-inflammatory and anti-acne effects of Hamamelis virginiana bark in human keratinocytes — in vitro. Antioxidants (Basel). https://pubmed.ncbi.nlm.nih.gov/35740016/
8. Janarthanam VA, Issac PK, Guru A, et al. (2025). In vitro and in silico evaluation of the antioxidant and anticancer potential of hamamelitannin from Hamamelis virginiana — in vitro/in silico. Cell Biochem Biophys. https://pubmed.ncbi.nlm.nih.gov/40549288/
9. Masaki H, Atsumi T, Sakurai H. (1995). Protective activity of hamamelitannin on cell damage induced by superoxide anion radicals in murine dermal fibroblasts — in vitro. Biol Pharm Bull. https://pubmed.ncbi.nlm.nih.gov/7735252/
10. Masaki H, Atsumi T, Sakurai H. (1995). Protective activity of hamamelitannin on cell damage of murine skin fibroblasts induced by UVB irradiation — in vitro. J Dermatol Sci. https://pubmed.ncbi.nlm.nih.gov/7577835/
11. Hartisch C, Kolodziej H, von Bruchhausen F. (1997). Dual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipoxygenase and lyso-PAF: acetyl-CoA acetyltransferase — in vitro. Planta Med. https://pubmed.ncbi.nlm.nih.gov/9140221/
12. Vennat B, Pourrat H, Pouget MP, et al. (1988). Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts — phytochemical analysis. Planta Med. https://pubmed.ncbi.nlm.nih.gov/17265314/
13. Mastihubová M, Mastihuba V. (2023). From hamamelitannin synthesis to the study of enzymatic acylations of D-hamamelose — review. Biomolecules. https://pubmed.ncbi.nlm.nih.gov/36979454/
14. Skowrońska W, Granica S, Piwowarski JP, et al. (2025). Chemical composition, skin microbiota metabolism, antimicrobial potential and anti-inflammatory properties of witch hazel bark (Hamamelis virginiana L.) — in vitro/ex vivo. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/40819781/
15. Wójciak M, Pacuła W, Sowa I, et al. (2025). Hamamelis virginiana L. in skin care: a review of its pharmacological properties and cosmetological applications — review. Molecules. https://pubmed.ncbi.nlm.nih.gov/40649262/
16. Dauer A, Hensel A, Lhoste E, et al. (2003). Genotoxic and antigenotoxic effects of catechin and tannins from the bark of Hamamelis virginiana L. in metabolically competent, human hepatoma cells (Hep G2) using single cell gel electrophoresis — in vitro. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/12711142/
17. Cobrado L, Silva-Dias A, Azevedo MM, et al. (2013). In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections — animal model. J Antimicrob Chemother. https://pubmed.ncbi.nlm.nih.gov/22991425/
18. Cobrado L, Azevedo MM, Silva-Dias A, et al. (2012). Cerium, chitosan and hamamelitannin as novel biofilm inhibitors? — in vitro. J Antimicrob Chemother. https://pubmed.ncbi.nlm.nih.gov/22316569/
19. Brackman G, Garcia-Fernandez MJ, Lenoir J, et al. (2016). Dressings loaded with cyclodextrin-hamamelitannin complexes increase Staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communities — in vitro. Macromol Biosci. https://pubmed.ncbi.nlm.nih.gov/26891369/
20. Janarthanam VA, Issac PK, Guru A, et al. (2026). Hamamelitannin from Hamamelis virginiana attenuates ethanol-induced oxidative and inflammatory responses in Danio rerio larvae — animal model. Mol Biotechnol. https://pubmed.ncbi.nlm.nih.gov/40906322/
21. Janarthanam VA, Issac PK, Guru A, et al. (2025). Evaluating the antioxidant-mediated neuroprotection of hamamelitannin against H2O2-induced oxidative damage — animal model. 3 Biotech. https://pubmed.ncbi.nlm.nih.gov/40556825/
22. Rippin, Sharma AK, Beniwal V. (2023). Ginnalin A and hamamelitannin: the unique gallotannins with promising anti-carcinogenic potential — review. Explor Target Antitumor Ther. https://pubmed.ncbi.nlm.nih.gov/37205316/
23. Touriño S, Lizárraga D, Carreras A, et al. (2008). Highly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells — in vitro. Chem Res Toxicol. https://pubmed.ncbi.nlm.nih.gov/18311930/
24. Theisen LL, Erdelmeier CAJ, Spoden GA, et al. (2014). Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus — in vitro. PLoS One. https://pubmed.ncbi.nlm.nih.gov/24498245/
25. González MJ, Torres JL, Medina I. (2010). Impact of thermal processing on the activity of gallotannins and condensed tannins from Hamamelis virginiana used as functional ingredients in seafood — in vitro. J Agric Food Chem. https://pubmed.ncbi.nlm.nih.gov/20222659/
26. Burico M, Fodaroni G, Flamini E, et al. (2022). Metabolomic fingerprint of Hamamelis virginiana L. gallotannins by suspect screening analysis with UHPLC-qToF and their semiquantitative evaluation — phytochemical analysis. J Mass Spectrom. https://pubmed.ncbi.nlm.nih.gov/36065819/
27. United States Pharmacopeia. Witch Hazel (Hamamelis Water) — official monograph. Distillate of recently cut, partially dried dormant twigs of Hamamelis virginiana; alcohol added to a final content of 14.0–15.0%. USP 29–NF 24. http://www.pharmacopeia.cn/v29240/usp29nf24s0_m89070.html
28. Haberland C, Kolodziej H. (1994). Novel galloylhamameloses from Hamamelis virginiana — phytochemical analysis. Planta Med. https://pubmed.ncbi.nlm.nih.gov/17236066/
29. Korting HC, Schäfer-Korting M, Klövekorn W, et al. (1995). Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema — double-blind randomised controlled trial. Eur J Clin Pharmacol. https://pubmed.ncbi.nlm.nih.gov/8582464/

View all 29 references▾